Article

Triac treatment prevents neurodevelopmental and locomotor impairments in thyroid hormone…

medRxiv · 2022 · Chen, J.; Salveridou, E.; Liebmann, L.; Sundaram, S. M.; Doycheva, D.; Markova, B.; Huebner, C. A.; Boelen, A.; Visser, W. E.; Heuer, H.; Mayerl, S.

Key facts

Title Triac treatment prevents neurodevelopmental and locomotor impairments in thyroid hormone transporter Mct8/Oatp1c1 deficient mice
First author Chen, J.; Salveridou, E.; Liebmann, L.; Sundaram, S. M.; Doycheva, D.; Markova, B.; Huebner, C. A.; Boelen, A.; Visser, W. E.; Heuer, H.; Mayerl, S.
Journal medRxiv
Published Oct 10, 2022
DOI 10.1101/2022.10.07.511125
Devices mentioned 021877

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature